Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT 23: IFR SWEDEHEART
Author(s): Matthias Gotberg Added: 1 year ago
TCT 23 - We are joined by Dr Matthias Götberg (Lund University, SE) to discuss recent findings from a study of the SWEDEHEART Registry, where the long-term outcomes of iFR vs FFR guided coronary revascularization were compared. Results suggest that in a national registry analysis of 42887 patients investigated with iFR or FFR with 5-year follow-up, similar outcomes were observed in MACE, all… View more

Prevention & Chronic Conditions

Intervention
ESC 24: The EARTH-STEMI Meta-Analysis
Author(s): Gianluca Campo Added: 8 months ago
ESC Congress 2024 — Complete revascularisation is safe, reduces ischemic events for up to 4 years, and does not affect long-term mortality.We are joined onsite by Dr Gianluca Campo (University of Ferrara, Ferrara, IT) to discuss the findings from EARTH-STEMI. Previous RCTs have supported the benefit of complete revascularisation in the overall population, however, this has not been confirmed in… View more

Intervention
Management of Left Main Coronary Artery Disease
Author(s): Gabriel Torres-Ruiz , Nuria Mallofré-Vila , Paola Rojas-Flores , et al Added: 1 year ago

Prevention & Chronic Conditions

Intervention
ESC 24: EPIC-CAD: Edoxaban vs Dual Antiplatelet Therapy in AF & CAD
Author(s): Gi-Byoung Nam , Min Soo Cho Added: 8 months ago
ESC Congress 2024 — Edoxaban monotherapy significantly improves outcomes in high-risk patients with CAD and atrial fibrillation.Investigators, Dr Gi-Byoung Nam (Ulsan University Hospital, Ulsan, SK) and Dr Min Soo Cho (Asan Medical Center, Seoul, SK) join us to discuss the key findings from the EPIC-CAD trial (NCT03718559).This Korean multi-centre, open-labelled, randomised controlled study… View more

Anticoagulation

Electrophysiology & Arrhythmia
SUCCESS PTA: 12-Month Data from SELUTION SLR™ DEB
Author(s): Michael Lichtenberg Added: 1 week ago
12 Month Outcomes of the SUCCESS PTA Study show consistent safety and effectiveness in claudicant and CLTI patients when using the SELUTION SLR™ drug eluting balloon.Dr Michael Lichtenberg (Vascular Centre Clinic Arnsberg, Arnsberg, DE) joins us to discuss the SUCCESS PTA study, a prospective, observational global registry evaluating the SELUTION SLR DEB in 723 patients across Europe, Asia and… View more

Intervention

Vascular Disease and Surgery
Lukla Biasi
Research Area(s) / Expertise:

Peripheral Artery Disease - General

 Job title: Consultant Vascular & Endovascular Surgeon
Dr Lukla Biasi is an experienced vascular and endovascular surgeon with a dedicated commitment to the sub-specialties of lower limb revascularisation and carotid surgery. Lukla Biasi graduated with distinguished honours from the University of Bologna, Italy; following a research fellowship at St Georges’ Vascular Institute in London, he completed the specialist training at the University… View more
Research Area(s) / Expertise:
Job title: Interventional Cardiologist
Dr Sanjog Kalra is an Interventional Cardiologist at University of Toronto, Toronto, CA. He specialises in complex, high risk coronary revascularisation, chronic total occlusion and mechanical circulatory support. View more
ESC 24: NOTION-3: FFR Guided PCI in TAVI
Author(s): Jacob Thomsen Lønborg Added: 8 months ago
ESC Congress 2024 — FFR-guided PCI improves outcomes in TAVI patients with coronary artery disease.Principal investigator, Prof Jacob Thomsen Lønborg (Rigshospitalet, DK) joins us to discuss the NOTION-3 trial (NCT03058627). A multinational, open-label, investigator-initiated trial evaluated the efficacy of FFR-guided PCI versus medical therapy in managing coronary artery disease (CAD) among… View more

Imaging & Diagnostics

Intervention
PERFORMANCE II: Two-Year Outcomes
Author(s): William Gray Added: 2 weeks ago
Safety and effectiveness outcomes of a 3-in-1 carotid stent delivery system show no major strokes at 30-day and one-year follow ups and significantly low rates of clinically driven target lesion revascularisation at two years.Dr William Gray (Main Line Health, Pennsylvania, US) joins us to discuss the first European presentation of the two-year outcomes from PERFORMANCE II (NCT04201132; Contego… View more

Vascular Disease and Surgery